ArticleRevista da Sociedade Brasileira de Medicina Tropical2024
Temporal trends and spatial analysis of leprosy surveillance indicators in the municipalities of the state of Mato Grosso, 2008-2022.
Article in Revista da Sociedade Brasileira de Medicina Tropical, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn 2022, Mato Grosso (MT, Brazil) reported the highest detection rate of new leprosy cases (66.20 per 100,000 inhabitants) among all Brazilian states. Monitoring of leprosy indicators is an important control strategy in hyperendemic areas. We aimed to describe the temporal trends and identify clusters of municipalities according to leprosy surveillance indicators in MT between 2008 and 2022.
methodsData from the Notifiable Diseases Information System were used to analyze new case detection rate of leprosy (NCDR), new case detection rate of leprosy among children aged <15 years (NCD15), and rate of new cases with grade 2 physical disability (G2DR). Spatial scan statistics with pure spatial analysis and spatial autocorrelation maps were used to analyze the spatial patterns. Joinpoint regression was used to estimate the annual percentage change (APC) in these indicators.
resultsThe NCDR decreased (APC: -20.2%, 95% confidence interval (CI): -38.7% to -7.4%) between 2019 and 2021. The NCD15 also decreased (APC: -19.2%, 95% CI: -36.4% to -10.3%) between 2018 and 2022. Conversely, the G2DR remained stable throughout the study (APC: 3.2%, 95% CI: -0.1% to 6.7%). Global Moran's index (Moran's I) confirmed the existence of spatial dependence among the municipalities for NCDR (Moran's I=0.348), NCD15 (Moran's I=0.269), and G2DR (Moran's I=0.275). Clusters with high NCDR levels included 13 municipalities in the northern and eastern macroregions, while clusters with high G2DR levels included 12 municipalities in the northwestern, northern, and eastern macroregions.
conclusionsThe NCDR and NCD15 decreased, but the G2DR remained stable between 2018 and 2022. The coronavirus disease 2019 (COVID-19) pandemic had a potential negative impact on leprosy case detection, highlighting the need to strengthen leprosy surveillance efforts. The identified clusters of MT municipalities can significantly assist in this task.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.